PLN and diabetic cardiomyopathy: Previous studies show the impairment of SR function in diabetic cardiomyopathy is caused by reduced activity of the SR calcium pump (SERCA2a) due primarily to a decrease in SERCA2a expression [10], [13]–[15] and a 2–4 fold increase in expression of phospholamban (PLB) [10].